Does Clinical Research Help Pemphigus Patients? Precautions and Suggestions

Publisher： Karger

E-ISSN： 1421-9832|203|3|199-200

ISSN： 1018-8665

Source： Dermatology, Vol.203, Iss.3, 2001-11, pp. : 199-200

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Precautions and Suggestions for Pemphigus Patients

By  

Dermatology, Vol. 203, Iss. 3, 2001-11 ,pp. : 201-207

Karger

Access to resources Recommend Favorite

Clinical and Immunological Follow-Up of Pemphigus Patients on Adjuvant Treatment with Immunoadsorption or Rituximab

By  

Dermatology, Vol. 218, Iss. 3, 2008-12 ,pp. : 237-245

Karger

Access to resources Recommend Favorite

Pilot Study of 19 Patients with Severe Pemphigus: Prophylactic Treatment with Rituximab Does Not Appear to be Beneficial

By  

Dermatology, Vol. 228, Iss. 2, 2014-02 ,pp. : 158-165

Karger

Access to resources Recommend Favorite

Prolonged Clinical Remission of Patients with Severe Pemphigus upon Rapid Removal of Desmoglein-Reactive Autoantibodies by Immunoadsorption

By  

Dermatology, Vol. 212, Iss. 2, 2006-03 ,pp. : 177-187

Karger

Access to resources Recommend Favorite

Cytokine Pattern in Blister Fluid and Sera of Patients with Pemphigus

By  

Dermatology, Vol. 205, Iss. 2, 2002-08 ,pp. : 116-121

Karger

Access to resources Recommend Favorite